Cross-fund · 5 holders
MGX
METAGENOMI THERAPEUTICS INC
CUSIP 59102M104
5
Tracked holders
$2.6M
Aggregate value
1,699,203
Shares
5
Active funds
Funds holding MGX
| Fund | Strategy | Period | Value | % of book | Δ shares | Status |
|---|---|---|---|---|---|---|
| Vanguard | Institutional | Q4 2025 | $2.1M | — | +28,736 | +2.3% |
| BlackRock | Institutional | Q1 2026 | $308,379 | — | +5,993 | +2.7% |
| Millennium | Multi-Strategy | Q1 2026 | $227,939 | — | -65,081 | -27.7% |
| Citadel | Multi-Strategy | Q1 2026 | $22,771 | — | -161,179 | -90.5% |
| Point72FEAT | Multi-Strategy | Q1 2026 | $15,713 | — | -14,863 | -55.9% |
Aggregated from the latest 13F-HR per tracked fund (longs only). QoQ deltas compare against each fund's prior quarterly filing.